Latest News on AstraZeneca (AZN) Stock

  • Top Stock Research Reports for Roche, Royal Dutch Shell & Citigroup [January 21 2020 10:53 AM]
  • Top Stock Research Reports for Roche, Royal Dutch Shell & Citigroup Read more about this AstraZeneca (AZN) news
  • Myriad Submits sPMA for BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Metastatic Castration-resistant Prostate Cancer [January 21 2020 05:05 AM]
  • Myriad Genetics, Inc. (MYGN), a leader in molecular diagnostics and precision medicine, announced today that it has submitted a supplementary premarket approval (sPMA) application to the U.S. Food and Drug Administration (FDA) for its BRACAnalysis® CDx test as a companion diagnostic to AstraZeneca’s (LSE/OMX Nordic/NYSE: AZN) and Merck’s PARP inhibitor Lynparza® (olaparib) for men with metas... Read more about this AstraZeneca (AZN) news




  • AstraZeneca Announces Positive FDA Updates on Cancer Drugs [January 20 2020 07:03 AM]
  • AstraZeneca's (AZN) label expansion application for Lynparza in a prostate cancer indication gets priority review from the FDA. Imfinzi and pipeline candidate, tremelimumab get orphan drug status for liver cancer. Read more about this AstraZeneca (AZN) news

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center